Tyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism. [electronic resource]
Producer: 20141020Description: 484-93 p. digitalISSN:- 1365-2559
- Aged
- Angiogenesis Inhibitors -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- blood supply
- Female
- Humans
- Indoles -- therapeutic use
- Kidney Neoplasms -- blood supply
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neovascularization, Pathologic -- drug therapy
- Nephrectomy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrroles -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Retrospective Studies
- Sorafenib
- Sunitinib
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.